This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
0,00009260 €
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Total liabilities
Total liabilities on the balance sheet as of March 2022 : €24.44 Million
According to Genocea Biosciences 's latest financial reports the company's total liabilities are €24.44 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Genocea Biosciences - Total liabilities on balance sheet (from 2012 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2021-12-31 | €25.51 M | -64.94% |
| 2020-12-31 | €72.77 M | 195.71% |
| 2019-12-31 | €24.61 M | 18.39% |
| 2018-12-31 | €20.78 M | 5.96% |
| 2017-12-31 | €19.61 M | -15.28% |
| 2016-12-31 | €23.15 M | 12.62% |
| 2015-12-31 | €20.56 M | 39.51% |
| 2014-12-31 | €14.73 M | 42.03% |
| 2013-12-31 | €10.37 M | 89.95% |
| 2012-12-31 | €5.46 M | 167.3% |
| 2011-12-31 | €2.04 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | €0.49 B | 1,917.55% | 🇺🇸 USA |
 | €2.02 B | 8,172.77% | 🇺🇸 USA |
 | €65.49 B | 267,801.37% | 🇺🇸 USA |
 | €7.22 M | -70.45% | 🇺🇸 USA |
 | €115.65 B | 472,948.52% | 🇺🇸 USA |